Home > Food & Beverages > Nutraceuticals > Herbal Supplements > Isoflavones Market

Isoflavones Market Trends

Report ID: GMI3077
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Isoflavones Market Trends

High risk of health complications, such as Kawasaki disease (KD) related to the long-term consumption of large amounts of soy products is expected to hamper the isoflavones market demand. Soy isoflavones can be difficult to digest and can cause constipation, diarrhea, and other digestive problems. Additionally, isoflavones are also considered for reacting with certain treatments for conditions such as cystic fibrosis, kidney stones, and hyperthyroidism. The compound is also known to have certain side effects on female reproductive health with abnormal tissue growth in the uterus, and poor development of the reproductive system in case of long-term exposure to isoflavone genistein.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of isoflavones reached USD 16.5 billion in 2022 and is anticipated to witness over 5% CAGR from 2023 to 2032.

The soy isoflavones segment is estimated to surpass USD 26 billion by the end of 2032, owing to the growing consumer inclination toward plant-based protein.

The market size for isoflavones in North America is projected to grow at 4.8% CAGR between 2023 and 2032, driven by the advent of veganism and plant-based diets in the region.

ADM, Medisys Biotech, Fujicco Co., Ltd, SK Bioland, Aushadhi Herbal, HerboNutra, Frutarom Ltd., Guzen Development, and Tradichem are some of the leading manufacturers and suppliers of isoflavones across the world.